Does insurance cover your GLP-1?

Check your plan and savings options

Use these questions to find the rules that apply to your prescription. They are a checklist, not a fixed approval process.

Why the plan name matters

Two people with the same insurer can have different benefits. Use the documents for your plan, whether you bought it yourself or get it through work.

Some employers fund their own health plans and hire an insurer to handle claims. In that case, the employer’s benefit choices also affect coverage. This is called a self-insured plan.

Does Aetna, Blue Cross Blue Shield, UnitedHealthcare or Cigna cover it?

The insurer’s name alone does not identify your coverage. Sign in to your member account and choose the drug list for your exact plan.

If you cannot find it, call the member-services number on your insurance card. Ask whether your prescribed drug and form are covered for your use, whether approval is needed, and what you would pay. Request the relevant plan document or criteria with the answer.

How coverage affects a savings-card offer

Commercial insurance is required for these Zepbound offers. Medicare and Medicaid do not qualify. Your plan’s coverage and the drug form determine which offer you can check.

Read from Eli Lilly and Company — manufacturer program terms · retrieved 2026-08-12

A category exclusion means the plan pays nothing for that category. It does not by itself decide savings-card eligibility. Zepbound publishes offers for commercial plans that do not cover the named presentation; the card’s separate eligibility terms decide whether one of those offers applies.

See all Zepbound prices and savings terms for the full eligibility rules and self-pay options.

Does Medicare cover these?

Check your Part D plan for coverage of your prescribed use. The separate Medicare GLP-1 Bridge offers a $50 a month copay for eligible people and specific products. Manufacturer savings cards exclude Medicare.

The Medicare GLP-1 Bridge runs from 2026-07-01 to 2027-12-31 and does not reach every product or device. Medicare lists these exact presentations:

• Foundayo (tablet)
• Wegovy (injection or tablet)
• Zepbound (KwikPen only. The program doesn’t cover single-dose Zepbound vials or pens)

The Bridge also says a person is not eligible in either of these situations:

• You already get GLP-1 drugs covered through your Medicare Part D plan.
• You have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. Medicare says your Part D plan might cover the drug for those.

Those are Bridge-specific rules. For the conditions in the second item, Medicare says a Part D plan might cover the drug for those indications. That answer belongs to the person’s own formulary and plan rules.

Check the Medicare Bridge eligibility rules for the required conditions, covered forms and exclusions.

Read from Centers for Medicare & Medicaid Services — federal program page · retrieved 2026-08-12

Does Medicaid cover these?

Check your state Medicaid program or managed-care plan for the drug and prescribed use. The manufacturer savings cards listed here exclude Medicaid.

For example, these are the government-program exclusions in the Foundayo Savings Card terms.

“You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE/CHAMPUS, or any state prescription drug assistance program”

Foundayo Savings Card terms · retrieved 2026-09-06

The Bridge requires eligible Medicare Part D coverage; Medicaid enrollment alone does not answer whether that requirement is met. Medicare lists Special Needs Plans and the Limited Income Newly Eligible Transition (LI NET) program among the Part D arrangements that can qualify. The other Bridge rules still apply. Separate from that federal route, each state decides what its own Medicaid program covers.

What to do after a denial

Start with the denial notice. It should explain the reason and how to dispute the decision. The next step depends on the reason and your plan’s review process.

1. Find the reason. Check whether the notice cites missing information, an approval requirement or a benefit exclusion. Ask the plan to identify the rule it used.
2. Get the relevant records. Your prescriber can help with medical information the plan requests. Ask what is missing before resubmitting the same request.
3. Follow the appeal instructions. Note the deadline and where to send the appeal. Ask the plan which review options apply, and keep copies of what you submit.

HealthCare.gov’s guide to appealing a denial explains internal appeals and independent external review.

You can also compare self-pay prices. Each offer has its own eligibility and refill rules; a denial does not establish that you qualify.

What you still need to check

Before filling your prescription, confirm the plan’s answer and the amount you would pay.

• Confirm your exact plan and current plan year before using a drug list.
• Ask your plan for your cost after any deductible, copay or coinsurance. A covered drug can still have an out-of-pocket cost.
• Check the savings program’s eligibility and caps separately. A plan exclusion does not establish card eligibility.
• Keep the plan’s response and any approval or denial notice. Note the dates for renewal or an appeal.

Where to read next

Compare the price and savings terms for your brand, or read its approved uses.

• Wegovy prices and savings terms — and what its label approves it for.
• Ozempic prices and savings terms — and what its label approves it for.
• Zepbound prices and savings terms — and what its label approves it for.
• Mounjaro prices and savings terms — and what its label approves it for.
• Trulicity prices and savings terms — and what its label approves it for.
• Victoza prices and savings terms — and what its label approves it for.
• Saxenda prices and savings terms — and what its label approves it for.
• Foundayo prices and savings terms — and what its label approves it for.
• Rybelsus prices and savings terms — and what its label approves it for.